ARMISTICE CAPITAL, LLC
CIK 1601086 · last filed 2023-06-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$308.43M
Companies
15
Total Filings
83
Lifetime Open-Market Net
$140.94M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVTX | Director | 765,828 | $14.76 | $11.30M | -$1.94M | 6 | 2023-06-28 |
| Avalo Therapeutics, Inc. (CERC) Delisted | Director | 39,662,442 | $2.93 | $116.21M | $51.07M | 15 | 2021-08-06 |
| Vyome Holdings, Inc (RSLS) Delisted | 10%+ Owner | 13,882,992 | $15.68 | $217.69M | $0 | 1 | 2021-06-29 |
| EYEG | Director | 6,693,202 | $35.27 | $236.07M | $36.97M | 10 | 2021-01-08 |
| AYTU | Director | 2,666,668 | $2.15 | $5.73M | $24.00M | 1 | 2020-12-15 |
| TENX | Director | 4,031,447 | $11.48 | $46.28M | $277.6K | 2 | 2020-09-09 |
| Vaxart, Inc. (VXRT) Delisted | Director | 16,800,000 | $0.32 | $5.38M | -$1.57M | 1 | 2020-05-29 |
| AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | 10%+ Owner | 4,468,000 | — | — | $1.25M | 2 | 2020-03-18 |
| Traws Pharma, Inc. (ONTXW) Delisted | 10%+ Owner | 1,633,404 | $0.07 | $109.6K | -$39.0K | 1 | 2019-09-25 |
| ACHV | 10%+ Owner | 1,638,170 | $5.52 | $9.04M | -$404.5K | 1 | 2019-06-13 |
| Del Frisco's Restaurant Group, Inc. (DFRG) Delisted | 10%+ Owner | 6,525,000 | — | — | $29.99M | 11 | 2019-06-06 |
| Valeritas Holdings Inc. (VLRX) Delisted | 10%+ Owner | 2,116,000 | — | — | $465.8K | 4 | 2019-05-28 |
| CASSAVA SCIENCES INC (PTIE) Delisted | 10%+ Owner | 1,651,340 | — | — | -$2.02M | 1 | 2018-10-05 |
| Fresh Tracks Therapeutics, Inc. (VICL) Delisted | 10%+ Owner | 6,035,028 | — | — | $69.2K | 1 | 2018-06-22 |
| Avalo Therapeutics, Inc. (CERCW) Delisted | Director | 32,440,000 | — | — | $2.82M | 8 | 2018-04-23 |
Recent Filings · Page 8 of 9
83 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-05-22 | EYEG | Buy (P) | +5,175 | $2.9K | EDGAR |
| 2018-05-16 | EYEG | Buy (P) | +47,274 | $25.3K | EDGAR |
| 2018-05-08 | EYEG | Buy (P) | +411,690 | $190.4K | EDGAR |
| 2018-04-23 | Avalo Therapeutics, Inc. (CERCW) Delisted | Buy (P) | +60,000 | $225.4K | EDGAR |
| 2018-04-18 | EYEG | — | — | $0 | EDGAR |
| 2018-04-17 | EYEG | Buy (P) | +31,439,910 | $11.22M | EDGAR |
| 2017-11-24 | Avalo Therapeutics, Inc. (CERCW) Delisted | Buy (P) | +135,600 | $162.6K | EDGAR |
| 2017-09-01 | Avalo Therapeutics, Inc. (CERCW) Delisted | Buy (P) | +118,437 | $89.6K | EDGAR |
| 2017-08-24 | Avalo Therapeutics, Inc. (CERCW) Delisted | Buy (P) | +240,870 | $158.4K | EDGAR |
| 2017-08-21 | Avalo Therapeutics, Inc. (CERCW) Delisted | Buy (P) | +439,584 | $264.5K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.